CRT-D replacement strategy: results of the BioCONTINUE study

Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Linde C, et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med. 2001;344:873–80.

Article  CAS  PubMed  Google Scholar 

Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49.

Article  CAS  PubMed  Google Scholar 

Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50.

Article  CAS  PubMed  Google Scholar 

Manfredi JA, Al-Khatib SM, Shaw LK, Thomas L, Fogel RI, Padanilam B, et al. Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias. Circ Arrhythm Electrophysiol. 2013;6:257–64.

Article  PubMed  Google Scholar 

Van Welsenes GH, van Rees JB, Borleffs CJW, Cannegieter SC, Bax JJ, van Erven L, et al. Long-term follow up of primary and secondary prevention implantable cardioverter defibrillator patients. Europace. 2011;13:389–94.

Article  PubMed  Google Scholar 

Alsheikh-Ali AA, Homer M, Maddukuri PV, Kalsmith B, Estes NAM III, Link MS. Time-dependence of appropriate implantable defibrillator therapy in patients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2008;19:784–9.

Article  PubMed  Google Scholar 

Al-Khatib SM, Friedman DJ, Sanders GD. When is it safe not to re-implant an implantable cardioverter defibrillator at the time of battery depletion? Card Electrophysiol Clin. 2018;10:137–44.

Article  PubMed  PubMed Central  Google Scholar 

Sebag FA, Lellouche N, Chen Z, Tritar A, O’Neill MD, Gill J, et al. Positive response to cardiac resynchronization therapy reduces arrhythmic events after elective generator change in patients with primary prevention CRT-D. J Cardiovasc Electrophysiol. 2014;12:1368–75.

Article  Google Scholar 

Kini V, Soufi MK, Deo R, Epstein AE, Bala R, Riley M, et al. Appropriateness of primary prevention implantable cardioverter-defibrillators at the time of generator replacement: are indications still met? J Am Coll Cardiol. 2014;63:2388–94.

Article  PubMed  PubMed Central  Google Scholar 

Kawata H, Hirai T, Doukas D, Hirai R, Steinbrunner J, Wilson J, et al. The occurrence of implantable cardioverter defibrillator therapies after generator replacement in patients who no longer meet primary prevention indications. J Cardiovasc Electrophysiol. 2016;27:724–9.

Article  PubMed  Google Scholar 

Narducci ML, Biffi M, Ammendola E, Vado A, Campana A, Potenza DR, et al. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis. Europace. 2018;20:1475–83.

Article  PubMed  Google Scholar 

Yuyun MF, Erqou SA, Peralta AO, Hoffmeister PS, Yarmohammadi H, Echouffo Tcheugui JB, et al. Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis. Europace. 2021;23:1262–74.

Article  PubMed  Google Scholar 

Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device- based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2013;127:e283-352.

Article  PubMed  Google Scholar 

Wu KC, Gerstenblith G, Guallar E, Marine JE, Dalal D, Cheng A, et al. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death. Circ Cardiovasc Imaging. 2012;5:178–86.

Article  PubMed  PubMed Central  Google Scholar 

Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021;42:3427–520.

Article  PubMed  Google Scholar 

Zegard A, Okafor O, de Bono J, Kalla M, Lencioni M, Marshall H, et al. Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction >35. Europace. 2022;24:31–9.

Article  PubMed  Google Scholar 

Russo AM, Stainback RF, Bailey SR, Epstein AE, Heidenreich PA, Jessup M, et al. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy. Heart Rhythm. 2013;10:1318–68.

Article  Google Scholar 

留言 (0)

沒有登入
gif